why choose us

First received: September 07, 2023

Clinical Trial: Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Branch Atheromatous Disease

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Tirofiban in Patients With Acute Branch Atheromatous Disease (BAD)- Related Stroke (BRANT)

Brief Summary: Branch atheromatous disease (BAD)-related stroke, characterized by subcortical single infarcts without severe stenosis of the large artery, but with a clear atherosclerotic mechanism, is now regarded as a separate stroke type.BAD is associated with early neurological deterioration and poor prognosis, but is lack of effective therapy.The goal of this randomized controlled trial is to test the efficacy and safety of intravenous tirofiban in patients with acute ischemic stroke caused by branch atheromatous…

Read more